Drug repositioning in sarcomas and other rare tumors

EBioMedicine. 2016 Apr:6:4-5. doi: 10.1016/j.ebiom.2016.03.021. Epub 2016 Mar 17.

Authors

Alex T J Lee¹, Paul H Huang², Seth M Pollack³, Robin L Jones⁴

Affiliations

¹ Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK.
² Institute of Cancer Research, London, UK.
³ Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA.
⁴ Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: [email protected].

No abstract available

Keywords: Angiosarcoma; Drug development; Drug repositioning; Sarcomas.

MeSH terms

Antineoplastic Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols
Drug Repositioning / economics
Drug Repositioning / methods*
Humans
Propranolol / therapeutic use
Rare Diseases / drug therapy
Sarcoma / drug therapy*
Vinblastine / therapeutic use

Substances

Antineoplastic Agents
Vinblastine
Propranolol